# KETAMINE HYDROCHLORIDE
> **ANDA219684** · Abbreviated New Drug Application (Generic) · Sponsor: BAXTER HLTHCARE CORP · Approved 2025-09-17
## Drug
- **FDA Application Number:** ANDA219684
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** KETAMINE HYDROCHLORIDE
- **Generic name:** KETAMINE HYDROCHLORIDE
- **Active ingredients:** KETAMINE HYDROCHLORIDE
- **Dosage form:** SOLUTION
- **Route:** INTRAMUSCULAR, INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** BAXTER HLTHCARE CORP
- **Manufacturer:** Baxter Healthcare Corporation
- **First approval:** 2025-09-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219684)
---
*MORVS · CC0 1.0*